NCT06524024 2025-02-10DC-CTLZhengzhou Revo-Gene Technology Co., LTDPhase NA Not yet recruiting20 enrolled
NCT06245018 2024-02-07A Trial to Evaluate the Safety and Preliminary Efficacy of iNK in the Treatment of Subjects With Solid TumorNuwacell Biotechnologies Co., Ltd.Phase NA Not yet recruiting50 enrolled